Viridian Therapeutics Inc

VRDN | $15.17 0.6% 0.59% 580K

(0.0% 1d) (-12.4% 1m) (-48.4% 1y) (0.0% 2d) (-0.1% 3d) (-5.1% 7d) (-2.73% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 952,184,037
http://www.miragen.com/
Sec Filling | Patents | 27 employees

(US) Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.

treatment antibody

add to watch list Paper trade email alert is off

BioCorRx Inc.

BICX | $1.47 201.91% 200

Health Care and Social Assistan...

(0.0% 1d) (63.3% 1m) (-26.1% 1y) (0.0% 2d) (0.0% 3d) (-2.0% 7d) (9900.0% volume)
Earnings Calendar:
Market Cap: $ 13,051,469
https://www.biocorrx.com/
Sec Filling | Patents | 3 employees

(United States) a company that changes lives biocorrx® is a leading edge healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. designed to treat alcoholism and certain opioid addictions, the biocorrx® recovery program is used by a network of independently owned and operated treatment centers located throughout the united states. the program consists of a proprietary long-lasting implant of the fda approved medication, naltrexone, which is proven to substantially reduce cravings for drugs and alcohol. it's a high-quality, comprehensive and cost- effective recovery program built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering addicts.

education

add to watch list Paper trade email alert is off